Arthritis Associated with Low Dose Methimazole Therapy: A Case Report Arthritis associated with Methimazole therapy
Iranian Journal of Pharmaceutical Sciences,
Vol. 14 No. 4 (2018),
1 October 2018
,
Page 55-62
https://doi.org/10.22037/ijps.v14.40625
Abstract
Here in this paper, we report a 31-year-old case admitted with symptoms of hyperthyroidism that was then diagnosed with Grave's disease (GD) and underwent treatments with a low dosage of methimazole (10 mg/day). 20 days after treatments initiations, she developed antithyroid arthritis syndrome. This patient experienced arthritis and arthralgia in at least 4 joints. All autoimmune and microbiologic evaluations were negative. She was then completely recovered without any sequelae within 4 days after drug withdrawal. Arthritis as an adverse effect of methimazole is a major and life-threatening adverse effect which requires immediate drug discontinuation and hospitalization. Contrary to what has been thought. We declare that this adverse effect might not be dose dependent as our case developed arthritis following methimazole therapy with a very low dosage (10 mg/day). The aim of the current case report is to help other physicians in order to diagnose and treat possible cases of antithyroid arthritis syndrome.
- hyperthyroidism
- Grave's disease
- antithyroid therapy
- methimazole
- arthritis
- case report
How to Cite
References
[2] L.J. DeGroot, Diagnosis and treatment of Graves’ disease, (2016).
[3] D.S. Cooper, Antithyroid drugs, N. Engl. J. Med. (2005) 352:905-917.
[4] H. Nakamura, J.Y. Noh, K. Itoh, S. Fukata, A. Miyauchi, N. Hamada, Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease, J. Clin. Endocrinol. Metab. (2007) 92:2157-2162.
[5] C.N. Gruber, K. Finzel, B.L. Gruber, A case of methimazole-induced chronic arthritis masquerading as seronegative rheumatoid arthritis, Int. J. Clin. Rheumtol. (2014) 20:229-232.
[6] J.-Y. Seo, H.-J. Byun, K.-H. Cho, E.B. Lee, Methimazole-induced bullous systemic lupus erythematosus: a case report, .J Korean Med. Sci. (2012) 27:818-821.
[7] L.-C. Wang, W.-Y. Tsai, Y.-H. Yang, B.-L. Chiang, Methimazole-induced lupus erythematosus: a case report, J. Microbiol. Immunol. Infect. (2003) 36:278-281.
[8] A.B. Emiliano, L. Governale, M. Parks, D.S. Cooper, Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008, J. Clin. Endocrinol. Metab. (2010) 95:2227-2233.
[9] D.M. Arab, D.A. Malatjalian, R.S. Rittmaster, Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole, J. Clin. Endocrinol. Metab. (1995) 80:1083-1085.
[10] D.S. Cooper, The side effects of antithyroid drugs, The Endocrinologist (1999) 9:457-478.
[11] D.S. Cooper, Antithyroid drugs in the management of patients with Graves’ disease: an evidence-based approach to therapeutic controversies, J. Clin. Endocrinol. Metab. (2003) 88:3474-3481.
[12] M. Nakhjavani, N. Nikounezhad, A. Ashtarinezhad, F.H. Shirazi, Human Lung Carcinoma Reaction against Metabolic Serum Deficiency Stress, Iran. J. Pharm. Res. (2016) 15:817.
[13] N. Nikounezhad, M. Nakhjavani, F.H. Shirazi, Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin, J. Exp. Ther. Oncol. (2017) 12.
[14] F.H. Shirazi, A. Zarghi, F. Kobarfard, R. Zendehdel, M. Nakhjavani, S. Arfaiee, T. Zebardast, S. Mohebi, N. Anjidani, A. Ashtarinezhad, Remarks in successful cellular investigations for fighting breast cancer using novel synthetic compounds, in: Breast Cancer-Focusing Tumor Microenvironment, Stem cells and Metastasis, InTech. (2011)
[15] A. Modi, H. Amin, F. Morgan, Antithyroid arthritis syndrome, BMJ. Case Rep, (2017) bcr2016218459.
[16] K. Takya, N. Kimura, T. Hiyoshi, Antithyroid Arthritis Syndrome: A Case Report and Review of the Literature, J. Gen. Intern. Med. (2016) 55:3627-3633.
[17] A.-C. Paepegaey, M. Mavromati, P. Chanson, S. Salenave, Antithyroid arthritis syndrome, (2016).
[18] R. Shatai, M. Shapiro, D. Orenstein, R. Taragan, L. Shenkmn, The antithyroid arthritis syndrome reviewed, Arthritis Rheum. (1984) 27:227-229.
[19] W.M. Ploegstra, R.P. Boontje, A.W. Kamps, Arthritis associated with antithyroid therapy in a 15-year-old girl, J. pediatr. Pharmacol. Ther. (2011) 16:98-101.
[20] H. Nihei, H. Tada, Y. Naruse, M. Izawa, M. Kato, H. Okuno, A Nakamura, K. Ishizu, T. Hamajima, T. Tajima, Polyarthritis caused by methimazole in two Japanese patients with Graves’ disease, J. Clin. Res. Pediat.r Endocrinol. (2013) 5:270.
[21] R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, S. Rivkees, D. Ross, Hyperthyroidism: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists, Thyroid (2010) 1865-1867.
- Abstract Viewed: 347 times
- IJPS_Volume 14_Issue 4_Pages 55-62 Downloaded: 258 times